(Q28293763)
Statements
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group (English)
0 references
July 1995
0 references
45
0 references
7
0 references
1268-76
0 references